Olvera-Ruíz R, Flores-Sánchez JÁ, López-Escoto JM, Velázquez-González AE, Pérez-Mora GE

Language: Spanish
References: 11
Page: 79-83
PDF size: 263.01 Kb.

ABSTRACT

Background: In nowadays the cath labs must be equipped with diagnostic and treatment devices, permitted a total overview of patients. Case report: Female of 48 years old with chest pain during last three months related with physical efforts. She smoked and had digestive disorders. Physical examination and lab test confirm metabolic syndrome. Exercise test was clinically positive without electrocardiographic changes. Coronary angiograph with no significant lesions showed but during dye injection she had angina. Intravascular ultrasound performed with significant fibrolipid lesions treated with drug eluting stents. Conclusion: Intravascular ultrasound is a main diagnostic tool in actual cath labs.

REFERENCES

1. Proudfit WL, Shirey EK, Sones FM Jr. Selective cine coronary arteriography. Correlation with clinical findings in 1,000 patients. Circulation 1966; 33: 901-910.

2. KPijls NH, De Bruyne B, Peels K et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334: 1703-1708.

3. Böse D, von Birgelen C, Erbel R. Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis. J Am Coll Cardiol 2007; 49: 925-932.

4. Smith SC Jr. et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. J Am Coll Cardiol 2006; 47: e1-121.

5. Tobis JM et al. Intravascular ultrasound imaging of human coronary arteries in vivo. Circulation 1990; 81: 1575-1585).

6. Gibbons RJ et al. ACC/AHA 2002 Guideline update for exercise testing. www.acc.org/qualityandscience/clinical/guidelines/exercise/exercise_clean.pdf

7. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999; 83: 660-666.

8. Reaven GM. The metabolic syndrome: Requiescat in pace. Clinical Chemistry 2005; 51: 6:931-938.

9. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.

10. Boden WE et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007: 356-369.

11. Schömig A, Mehilli J, de Waha A, Seyfarth M, Pache J, Kastrati A. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 894-904.